Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05780> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05780 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05780 label "ATX-101 [drugbank:DB05780]" assertion.
- drugbank:DB05780 seeAlso DB05780 assertion.
- drugbank:DB05780 description "ATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. This includes treatment of superficial lipomas (benign tumors of soft tissue composed of mature fat cells), fat deposits in the submental region of the face/neck, and localized fat deposits in other parts of the body. Deoxycholic acid is a naturally occurring bile acid produced by the liver as one of several end products of cholesterol metabolism. As a naturally occurring component of the human body, deoxycholate is considered a âbiocompatibleâ detergent that solubilizes fat in the small intestine. ATX-101 demonstrates a relative selectivity for fat over other tissues." assertion.
- drugbank:DB05780 identifier "drugbank:DB05780" assertion.
- drugbank:DB05780 title "ATX-101" assertion.
- drugbank:DB05780 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05780 drugbank_vocabulary:drugbank-id "DB05780" assertion.
- drugbank:DB05780 bio2rdf_vocabulary:x-identifiers.org DB05780 assertion.
- drugbank:DB05780 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05780" assertion.
- drugbank:DB05780 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05780 bio2rdf_vocabulary:identifier "DB05780" assertion.